(Q36092123)

English

Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

0 references

Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

systematic review

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jiangbo Liu

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Qingyong Ma

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Min Zhang

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xinshuai Wang

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dong Zhang

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Wei Li

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Fengfei Wang

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Erxi Wu

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

27 March 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

48

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2328-2338

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Prognostic molecular markers in hepatocellular carcinoma: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 October 2017

Overexpression of p53 protein is not directly related to hepatitis B x protein expression and is associated with neoplastic progression in hepatocellular carcinomas rather than hepatic preneoplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 July 2018

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 July 2018

p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 July 2018

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

2 July 2018

The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

REporting recommendations for tumour MARKer prognostic studies (REMARK).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Prognostic significance of p53 overexpression after hepatic resection of hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

International trends and patterns of primary liver cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Trends in mortality from primary liver cancer in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

23 September 2018

[Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395767

21 October 2018

Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in france

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of serum biological markers in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase expression and p53 status in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22459764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.EJCA.2012.03.001

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36092123&oldid=1974378542"